Urology

Uzm. Dr. Murat Can Karaburun

Doctor and researcher Ankara Etlik Şehir Hastanesi Ankara
Urinary Bladder NeoplasmsKidney CalculiUrethral StrictureNon-Muscle Invasive Bladder NeoplasmsInfertility, MaleHypospadiasPainCystitis, Interstitial
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Urinary Bladder Neoplasms 5 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Kidney Calculi 4 publications
  • Urethral Stricture 3 publications
  • Non-Muscle Invasive Bladder Neoplasms 3 publications
  • Infertility, Male 2 publications
  • Hypospadias 2 publications
  • Pain 2 publications
  • Cystitis, Interstitial 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyUrologysaglik.gov.trFrom source
  • InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
  • Area of workUrinary Bladder NeoplasmsExtracted from 5 publications · Model version —From source
  • Publications59 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0001-6917-9051ORCIDFrom source
  • Last synchronised5 November 2026 07:23https://etliksehir.saglik.gov.tr/TR-864428/klinik-doktorlarimiz.html#murat-can-karaburunsaglik.gov.tr

Scientific work

Publications on Urinary Bladder Neoplasms

59 publications

  1. Early Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty for Female Urethral Stricture Disease: A Single-Center Experience

    Medicina, 2026

    DOI 10.3390/medicina62101976 PMID 42942507 Open-access full textSource: ORCID

  2. A prospective non-randomized trial comparing the efficacy and safety of pulsed Thulium:YAG versus Holmium:YAG lasers for prostate enucleation

    European Urology, 2026

    Source: ORCID

  3. Can Invasion of the Vas Deferens be Considered a Prognostic Marker in pT3b Prostate Cancer?

    Uroonkoloji Bulteni-bulletin of Urooncology, 2026

    DOI 10.4274/uob.galenos.2025.2025.6.3 Open-access full textSource: ORCID

  4. Long-term Outcomes of Two Dextranomer-based Bulking Agents (Dexell vs. Deflux) in the Endoscopic Treatment of Vesicoureteral Reflux

    Journal of Urological Surgery, 2026

    DOI 10.4274/jus.galenos.2025.2025-6-11 Open-access full textSource: ORCID

  5. Post-cycle therapy after short-term anabolic-androgenic steroid use: Comparative outcomes in recreational bodybuilders

    European Urology, 2026

    Source: ORCID

  6. Prostate-specific Antigen Density and Clinically Significant Prostate Cancer: Impact of Prostatic Volume in PI-RADS 3 Lesions; High Volume Single-center Analysis

    Uroonkoloji Bulteni-bulletin of Urooncology, 2026

    DOI 10.4274/uob.galenos.2025.2025.8.4 Open-access full textSource: ORCID

  7. Outcomes of Redo Dorsal Onlay Buccal Mucosal Graft Urethroplasty After Failed Ventral Urethroplasty in Women

    International Urogynecology Journal, 2026

    DOI 10.1007/s00192-026-06630-7 PMID 41945097 2 citations (Europe PMC) Open-access full textSource: ORCID

  8. Post‐cycle therapy after short‐term anabolic‐androgenic steroid use: comparative outcomes in recreational bodybuilders

    BJU International, 2026

    DOI 10.1111/bju.70059 PMID 41147237 1 citation (Europe PMC) Source: ORCID

  9. Rates of incidental prostate cancer following HoLEP: Can it be predicted preoperatively?

    Canadian Urological Association Journal, 2026

    DOI 10.5489/cuaj.9444 PMID 41848538 Open-access full textSource: ORCID

  10. P0822 Post-cycle therapy after short-term anabolic-androgenic steroid use: Comparative outcomes in recreational bodybuilders

    European Urology, 2026

    DOI 10.1016/s0302-2838(26)01682-9 Source: OpenAlex

View all 59 publications